Great coverage of TargetCancer Foundation’s support of an innovative esophageal cancer collaboration at the Dana-Farber Cancer Institute.
What started as a casual conversation over coffee has led to unexpected discoveries that are paving the way for effective use of immunotherapies to treat esophageal cancer.
This article first appeared in Dana-Farber Cancer Institute’s Inside the Institute and is reprinted with permission.
You can also learn more about TargetCancer Foundation’s ongoing esophageal cancer research funding here.